WeGovy contains semaglutide, a GLP-1 receptor agonist that helps reduce appetite, increase feelings of fullness, and slow down digestion
As a triple agonist with superior weight loss data, it may command a premium over existing dual agonists
The peptide was discovered during research on human gastric juice
Biologic medications, such as Glucagon-Like Peptide-1 (GLP-1) receptor agonists, promote weight loss and improve blood glucose levels
The Weight Regain Challenge Data from similar medications provides insight into what happens after discontinuation
But for perimenopausal and postmenopausal women, where adipose tissue becomes an increasingly important estrogen contributor, rapid fat loss can push estrogen levels low enough to cause symptoms